Aptevo Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.70

+0.69 (+11.48%)

As of Feb 8, 2:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +321.6% upside

Low Target $22.50

Average Target $28.25

High Target $48.31

Current Price $6.70

Current
$6.70

Target
$28.25

$22.50 $28.25 avg $48.31

Scenario Analysis

Bear Case

$22.50

235.8%

Low target

Base Case

$28.25

+321.6%

Avg target

Bull Case

$48.31

+621.0%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$41.06

-83.7% from high

52-Week Low

$23.15

+-71.1% from low

Target vs 52W High

$28.25

-31.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%